UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS)

Archives of internal medicine (1960), 2004-05, Vol.164 (10), p.1084

2004

Volltextzugriff (PDF)

The erlangen fitness osteoporosis prevention study: a controlled exercise trial in early postmenopausal women with low bone density—first-year results

Archives of physical medicine and rehabilitation, 2003-05, Vol.84 (5), p.673-682

2003

Volltextzugriff (PDF)

Exercise effects on menopausal Risk Factors of Early Postmenopausal Women: 3-yr erlangen fitness osteoporosis prevention study results

Medicine and science in sports and exercise, 2005-02, Vol.37 (2), p.194-203

2005

Volltextzugriff (PDF)

Effect of P‐glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine

British journal of clinical pharmacology, 2000-09, Vol.50 (3), p.237-246

2000

Volltextzugriff (PDF)

Current in vitro methods in nanoparticle risk assessment: Limitations and challenges

European journal of pharmaceutics and biopharmaceutics, 2009-06, Vol.72 (2), p.370-377

2009

Volltextzugriff (PDF)

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Schizophrenia research, 2009-09, Vol.113 (2), p.210-217

2009

Volltextzugriff (PDF)

Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis

Schizophrenia research, 2010-11, Vol.123 (2), p.160-174

2010

Volltextzugriff (PDF)

Long-acting injectable risperidone for the treatment of schizophrenia : Clinical perspectives

Drugs (New York, N.Y.), 2007, Vol.67 (11), p.1541-1566

MOLLER, Hans-Jürgen

2007

Volltextzugriff (PDF)

Attitude towards adherence in patients with schizophrenia at discharge

Journal of psychiatric research, 2009-12, Vol.43 (16), p.1294-1301

2009

Volltextzugriff (PDF)

Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin‐embedded specimens

Cancer, 1993-06, Vol.71 (12), p.3846-3850

1993

Volltextzugriff (PDF)

Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade

Biochemical pharmacology, 1994-08, Vol.48 (5), p.985-996

1994

Volltextzugriff (PDF)

Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement

Clinical pharmacology and therapeutics, 2001-11, Vol.70 (5), p.405-414

2001

Volltextzugriff (PDF)

Does Pharmacogenetic Testing for CYP450 2D6 and 2C19 Among Patients with Diagnoses within the Schizophrenic Spectrum Reduce Treatment Costs?

Basic & clinical pharmacology & toxicology, 2013-10, Vol.113 (4), p.266-272

2013

Volltextzugriff (PDF)

Increasing railway suicide acts after media coverage of a fatal railway accident? An ecological study of 747 suicidal acts

Journal of epidemiology and community health (1979), 2011-09, Vol.65 (9), p.825-828

2011

Volltextzugriff (PDF)

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia

Circulation (New York, N.Y.), 1999-08, Vol.100 (6), p.587-593

1999

Volltextzugriff (PDF)

Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial Disease

Clinical chemistry (Baltimore, Md.), 2007-07, Vol.53 (7), p.1298-1305

2007

Volltextzugriff (PDF)

Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment

American journal of kidney diseases, 2002-11, Vol.40 (5), p.916-923

2002

Volltextzugriff (PDF)

Lipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesis

Atherosclerosis, 1990-11, Vol.85 (1), p.1-14

1990

Volltextzugriff (PDF)

Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure

Kidney international, 1999-09, Vol.56 (3), p.1049-1057

1999

Volltextzugriff (PDF)

Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease

Journal of internal medicine, 2002-02, Vol.251 (2), p.111-118

2002

Volltextzugriff (PDF)

Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians

Atherosclerosis, 1999-11, Vol.147 (1), p.17-24

1999

Volltextzugriff (PDF)

Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA)

Acta neurologica Scandinavica, 1999-12, Vol.100 (6), p.395-399

1999

Volltextzugriff (PDF)

Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial

Journal of clinical epidemiology, 2001, Vol.54 (1), p.51-57

2001

Volltextzugriff (PDF)

Lipoprotein(a)-Associated Atherothrombotic Risk in Hemodialysis Patients

American journal of nephrology, 2004-03, Vol.24 (2), p.221-229

2004

Volltextzugriff (PDF)

Quantification of apo[a] and apoB in human atherosclerotic lesions

Journal of lipid research, 1991-02, Vol.32 (2), p.317-327

1991

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS)

The erlangen fitness osteoporosis prevention study: a controlled exercise trial in early postmenopausal women with low bone density—first-year results

Exercise effects on menopausal Risk Factors of Early Postmenopausal Women: 3-yr erlangen fitness osteoporosis prevention study results

Effect of P‐glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine

Current in vitro methods in nanoparticle risk assessment: Limitations and challenges

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis

Long-acting injectable risperidone for the treatment of schizophrenia : Clinical perspectives

Attitude towards adherence in patients with schizophrenia at discharge

Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin‐embedded specimens

Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade

Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement

Does Pharmacogenetic Testing for CYP450 2D6 and 2C19 Among Patients with Diagnoses within the Schizophrenic Spectrum Reduce Treatment Costs?

Increasing railway suicide acts after media coverage of a fatal railway accident? An ecological study of 747 suicidal acts

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia

Increased Serum Lipoprotein(a) Concentrations and Low Molecular Weight Phenotypes of Apolipoprotein(a) Are Associated with Symptomatic Peripheral Arterial Disease

Relationship of renal function to homocysteine and lipoprotein(a) levels: The frequency of the combination of both risk factors in chronic renal impairment

Lipoprotein (a) : structure, properties and possible involvement in thrombogenesis and atherogenesis

Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure

Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease

Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians

Vascular risk factors for atherosclerotic lesions of the middle cerebral artery detected by magnetic resonance angiography (MRA)

Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial

Lipoprotein(a)-Associated Atherothrombotic Risk in Hemodialysis Patients

Quantification of apo[a] and apoB in human atherosclerotic lesions

Aktive Filter

Suchergebnisse filtern